These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 6716270)

  • 21. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat.
    Ramarao P; Bhargava HN
    Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opiate antagonists reduce cocaine but not nicotine self-administration.
    Corrigall WA; Coen KM
    Psychopharmacology (Berl); 1991; 104(2):167-70. PubMed ID: 1876660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Narcotic antagonist-induced hypotension in the spontaneously hypertensive rat.
    Quock RM; Kouchich FJ; Vaughn LK; Fries DS
    Life Sci; 1985 Sep; 37(9):819-26. PubMed ID: 4033357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Within-session determination of dose-response curves for heroin self-administration in rats: Comparison with between-session determination and effects of naltrexone.
    Martin TJ; Walker LE; Sizemore GM; Smith JE; Dworkin SI
    Drug Alcohol Depend; 1996 Jun; 41(2):93-100. PubMed ID: 8809497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Operant analysis of human heroin self-administration and the effects of naltrexone.
    Mello NK; Mendelson JH; Kuehnle JC; Sellers MS
    J Pharmacol Exp Ther; 1981 Jan; 216(1):45-54. PubMed ID: 7452507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Training dose and session time as contextual determinants of heroin self-administration in rats.
    Martin TJ; Smith JE; Dworkin SI
    Pharmacol Biochem Behav; 1998 Jun; 60(2):415-21. PubMed ID: 9632224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opiate-receptor antagonist nalmefene improves neurological recovery after traumatic spinal cord injury in rats through a central mechanism.
    Faden AI; Sacksen I; Noble LJ
    J Pharmacol Exp Ther; 1988 May; 245(2):742-8. PubMed ID: 3367315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems.
    Ettenberg A; Pettit HO; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1982; 78(3):204-9. PubMed ID: 6296898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melatonin modifies prolactin release induced by opiate antagonists in male rats.
    Shacoori V; Saiag B; Rault B
    Endocr Res; 1995 Aug; 21(3):545-53. PubMed ID: 7588425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats.
    Heyser CJ; Roberts AJ; Schulteis G; Koob GF
    Alcohol Clin Exp Res; 1999 Sep; 23(9):1468-76. PubMed ID: 10512312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethers.
    Schmidhammer H; Leander JD; Mayer-Valkanover K; Nussbaumer C; Schmidt C; Schoepp DD; Schratz A; Walla-Kugler M
    Prog Clin Biol Res; 1990; 328():41-4. PubMed ID: 2154800
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of opiate antagonist treatment into either the periaqueductal grey or nucleus accumbens on heroin-induced locomotor activation.
    Vaccarino FJ; Corrigall WA
    Brain Res Bull; 1987 Nov; 19(5):545-9. PubMed ID: 3690365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of nucleus accumbens opiate receptors attenuates intravenous heroin reward in the rat.
    Vaccarino FJ; Bloom FE; Koob GF
    Psychopharmacology (Berl); 1985; 86(1-2):37-42. PubMed ID: 2991967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The structure-action relationship and kinetics of some naloxone and naltrexone derivatives.
    Vizi ES; Foldes FF; Rich J; Knoll J
    Pharmacology; 1976; 14(1):76-85. PubMed ID: 959310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limitations on the antagonistic actions of opioid antagonists.
    Young AM; Woods JH
    Fed Proc; 1982 May; 41(7):2333-8. PubMed ID: 7042396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A further assessment of a role for Toll-like receptor 4 in the reinforcing and reinstating effects of opioids.
    Yue K; Tanda G; Katz JL; Zanettini C
    Behav Pharmacol; 2020 Apr; 31(2&3):186-195. PubMed ID: 30741729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
    Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
    Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ; Somogyi AA; White JM
    Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for the delivery of narcotic antagonists to the colon as their glucuronide conjugates.
    Simpkins JW; Smulkowski M; Dixon R; Tuttle R
    J Pharmacol Exp Ther; 1988 Jan; 244(1):195-205. PubMed ID: 3335997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.